COCH Envoy Medical, Inc.

Nasdaq www.envoymedical.com


$ 0.69 $ -0.04 (-5.96 %)    

Thursday, 13-Nov-2025 11:52:19 EST
QQQ $ 611.97 $ -5.71 (-0.92 %)
DIA $ 478.64 $ -2.72 (-0.57 %)
SPY $ 676.15 $ -4.33 (-0.64 %)
TLT $ 89.85 $ 0.04 (0.05 %)
GLD $ 386.56 $ -0.72 (-0.19 %)
$ 0.7294
$ 0.70
$ 0.69 x 1,000
$ 0.69 x 100
$ 0.68 - $ 0.72
$ 0.67 - $ 2.32
592,959
na
15.94M
$ 0.24
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-10-2025 09-30-2025 10-Q
2 07-31-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 03-28-2025 12-31-2024 10-K
5 11-14-2024 09-30-2024 10-Q
6 08-12-2024 06-30-2024 10-Q
7 05-15-2024 03-31-2024 10-Q
8 04-01-2024 12-31-2023 10-K
9 11-17-2023 09-30-2023 10-Q
10 08-14-2023 06-30-2023 10-Q
11 05-15-2023 03-31-2023 10-Q
12 04-03-2023 12-31-2022 10-K
13 11-14-2022 09-30-2022 10-Q
14 08-15-2022 06-30-2022 10-Q
15 05-16-2022 03-31-2022 10-Q
16 03-31-2022 12-31-2021 10-K
17 11-12-2021 09-30-2021 10-Q
18 08-18-2021 06-30-2021 10-Q
19 05-17-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 envoy-medical-q3-eps-035-misses-028-estimate-sales-42000k-miss-70000k-estimate

Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.2...

 envoy-medical-enrolls-first-three-participants-in-final-stage-in-pivotal-clinical-study-of-full-implanted-acclaim-cochlear-implant

Envoy Medical, Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully...

 envoy-medical-granted-nasdaq-extension-until-february-23-2026-to-regain-full-compliance

Envoy Medical, Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully...

 envoy-medical-announces-it-is-scaling-its-commercialization-planning-for-the-companys-breakthrough-investigational-acclaim-fully-implanted-cochlear-implant-as-pivotal-trial-progresses

The Company Begins Strategic Preparations To Support Anticipated Demand And Optimization Of The Acclaim® Fully Implanted Cochle...

 envoy-medical-secures-european-patent-for-fully-implanted-cochlear-system-strengthening-ip-ahead-of-acclaim-launch

Patent covers advanced signal processing for middle ear sensors, further advancing the Company's position in leveraging the...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION